Alspaugh Jonathan 4
4 · Aeglea BioTherapeutics, Inc. · Filed Jun 30, 2023
Insider Transaction Report
Form 4
Alspaugh Jonathan
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-06-22+19,787,969→ 19,787,969 totalExercise: $0.30Exp: 2033-06-22→ Common Stock (19,787,969 underlying)
Footnotes (2)
- [F1]This option award is contingent upon receiving stockholder approval of the amendment and/or restatement of the 2016 Equity Incentive Plan to increase the number of shares available for issuance thereunder.
- [F2]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on July 22, 2023, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.